Androgen Deprivation Therapy in Prostate Cancer: Looking Beyond Prostate-specific Antigen and Testosterone Levels

被引：4
|
作者：
Saad, Fred [1 ]
机构：
[1] Univ Montreal, Ctr Hosp, Montreal, PQ H2L 4M1, Canada
来源：
EUROPEAN UROLOGY | 2015年 / 67卷 / 05期
关键词：
D O I：
10.1016/j.eururo.2014.08.033
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：837 / 838
页数：2
相关论文
共 50 条
  • [1] PROSTATE-SPECIFIC ANTIGEN AND ANDROGEN DEPRIVATION THERAPY
    RUCKLE, HC
    OESTERLING, JE
    WORLD JOURNAL OF UROLOGY, 1993, 11 (04) : 227 - 232
  • [2] Prostate-Specific Antigen Kinetics under Androgen Deprivation Therapy and Prostate Cancer Prognosis
    Zhang, Li-min
    Jiang, Hao-wen
    Tong, Shi-jun
    Zhu, Hui-qing
    Liu, Jun
    Ding, Qiang
    UROLOGIA INTERNATIONALIS, 2013, 91 (01) : 38 - 48
  • [3] Prostate-specific antigen decline pattern in advanced prostate cancer receiving androgen deprivation therapy and relationship with prostate-specific antigen progression
    Akbay, Erdem
    Bozlu, Murat
    Cayan, Selahittin
    Kara, Pelin Ozcan
    Tek, Mesut
    Aytekin, Cuma
    AGING MALE, 2017, 20 (03): : 175 - 183
  • [4] PROGNOSTIC VALUE OF PROSTATE-SPECIFIC ANTIGEN IN ADVANCED PROSTATE CANCER TREATED WITH ANDROGEN DEPRIVATION THERAPY AND ABIRATERONE
    Lou, L.
    Wei, J.
    Ma, S.
    Chen, W.
    Cao, X. -l.
    Sun, F. -h.
    WORLD CANCER RESEARCH JOURNAL, 2024, 11
  • [5] FIBROBLASTS PROLONG SERUM PROSTATE-SPECIFIC ANTIGEN DECLINE AFTER ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER
    Sasaki, Takeshi
    Ishii, Kenichiro
    Miki, Manabu
    Kanda, Hideki
    Arima, Kiminobu
    Shiraishi, Taizo
    Sugimura, Yoshiki
    JOURNAL OF UROLOGY, 2016, 195 (04): : E818 - E818
  • [6] Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer
    Sasaki, Takeshi
    Ishii, Kenichiro
    Iwamoto, Yoichi
    Kato, Manabu
    Miki, Manabu
    Kanda, Hideki
    Arima, Kiminobu
    Shiraishi, Taizo
    Sugimura, Yoshiki
    LABORATORY INVESTIGATION, 2016, 96 (03) : 338 - 349
  • [7] Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy
    Huang, Shu-Pin
    Bao, Bo-Ying
    Wu, Ming-Tsang
    Choueiri, Toni K.
    Goggins, William B.
    Liu, Chia-Chu
    Huang, Chao-Yuan
    Pu, Yeong-Shiau
    Yu, Chia-Cheng
    Wu, Tony T.
    Huang, Chun-Nung
    Huang, Chun-Hsiung
    Wu, Wen-Jeng
    AGING MALE, 2012, 15 (01): : 34 - 41
  • [8] Prostate-Specific Antigen Screening Trials and Prostate Cancer Deaths: The Androgen Deprivation Connection
    Haines, Ian E.
    Miklos, George L. Gabor
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (20): : 1534 - 1539
  • [9] How early is early: Androgen deprivation for prostate-specific antigen relapse in prostate cancer
    Duchesne, Gillian M.
    Syme, Rodney
    Howell, Deborah
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2964 - 2964
  • [10] Interpreting Testosterone and Concomitant Prostate Specific Antigen Values during Androgen Deprivation Therapy for Recurrent Prostate Cancer
    Tremblay, Samuel
    Summers-Trasiewicz, Lily
    Pouliot, Frederic
    Crook, Juanita M.
    Ding, Keyue
    Klotz, Laurence
    Toren, Paul
    JOURNAL OF UROLOGY, 2021, 206 (05): : 1166 - 1175
12345